Copyright
©The Author(s) 2019.
World J Gastroenterol. Nov 14, 2019; 25(42): 6354-6364
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6354
Published online Nov 14, 2019. doi: 10.3748/wjg.v25.i42.6354
Table 1 Baseline characteristics of study population, n (%)
Non-COPD controls (n = 6515105) | COPD group (n = 1303021) | P value | |
Sex (Male %) | 2867470 (44.0) | 573494 (44.0) | 1 |
Age (yr) | 57.1 ± 10.72 | 57.1 ± 10.72 | 1 |
40-64 | 5025580 (77.1) | 1005116 (77.1) | |
65- | 1489525 (22.9) | 297905 (22.9) | |
COPD severity | |||
Mild | 1191562 (91.4) | ||
Severe | 111459 (8.6) | ||
Income Low1 | 1597508 (24.5) | 357627 (27.5) | < 0.001 |
Urban residents | 2965581 (45.8) | 567359 (44.1) | |
Comorbidity | |||
Diabetes mellitus | 640544 (9.8) | 164860 (12.7) | < 0.001 |
Hypertension | 1703988 (26.2) | 418880 (32.2) | < 0.001 |
Dyslipidemia | 1002279 (15.4) | 272449 (20.9) | < 0.001 |
Follow up duration (yr) | 3.9 ± 1.4 | 3.9 ± 1.4 | 0.8803 |
Table 2 Incidence rate and risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease
Event | DURATION (Person-years) | Incidence rateof IBD | Model 11 HR (95%CI) | Model 22 HR (95%CI) | P value | ||
IBD | |||||||
COPD | No | 1846 | 25697723.08 | 7.18 | 1 (Ref.) | 1 (Ref.) | < 0.001 |
Yes | 513 | 5139283.39 | 9.98 | 1.39 (1.26-1.53) | 1.379 (1.25-1.52) | ||
UC | |||||||
COPD | No | 1540 | 25697723.08 | 5.99 | 1 (Ref.) | 1 (Ref.) | < 0.001 |
Yes | 406 | 5139283.39 | 7.9 | 1.32 (1.18-1.47) | 1.315 (1.18-1.47) | ||
CD | |||||||
COPD | No | 306 | 25697723.08 | 1.19 | 1 (Ref.) | 1 (Ref.) | < 0.001 |
Yes | 107 | 5139283.39 | 2.08 | 1.75 (1.40-2.171) | 1.691 (1.35-2.10) |
Table 3 Incidence and risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease according to disease severity
Event | DURATION (Person-years) | Incidence rateof IBD | Model 11 HR (95%CI) | Model 22 HR (95%CI) | P value | ||
IBD | |||||||
COPD Severity | Non | 1846 | 25697723.08 | 7.18 | 1 (Ref.) | 1 (Ref.) | < 0.001 |
Mild | 461 | 4719752.21 | 9.77 | 1.36 (1.23-1.50) | 1.35 (1.22-1.49) | ||
Sev-ere | 52 | 419531.18 | 12.39 | 1.717 (1.29-2.24) | 1.70 (1.27-2.21) | ||
UC | |||||||
COPD Severity | Non | 1540 | 25697723.08 | 5.99 | 1 (Ref.) | 1 (Ref.) | < 0.001 |
Mild | 371 | 4719752.21 | 7.86 | 1.31 (1.17-1.47) | 1.31 (1.17-1.47) | ||
Sev-ere | 35 | 419531.18 | 8.34 | 1.39 (0.97-1.91) | 1.38 (0.96-1.89) | ||
CD | |||||||
COPD Severity | Non | 306 | 25697723.08 | 1.19 | 1 (Ref.) | 1 (Ref.) | < 0.001 |
Mild | 90 | 4719752.21 | 1.91 | 1.60 (1.26-2.02) | 1.548 (1.22-1.95) | ||
Sev-ere | 17 | 419531.18 | 4.05 | 3.38 (2.00-5.33) | 3.29 (1.94-5.20) |
Table 4 Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease according to sex and age
COPD | IBD | UC | CD | |
Male | No | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 1.47 (1.23-1.60) | 1.35 (1.16-1.55) | 1.75 (1.26-2.39) | |
Female | No | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 1.35 (1.16-1.55) | 1.27 (1.07-1.5) | 1.64 (1.20-2.21) | |
Age (40-64) | No | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 1.36 (1.21-1.52) | 1.31 (1.15-1.48) | 1.62 (1.25-2.08) | |
Age (65-) | No | 1 (Ref.) | 1 (Ref.) | 1 (Ref.) |
Yes | 1.46 (1.19-1.79) | 1.36 (1.07-1.71) | 1.93 (1.23-2.96) |
- Citation: Lee J, Im JP, Han K, Park S, Soh H, Choi K, Kim J, Chun J, Kim JS. Risk of inflammatory bowel disease in patients with chronic obstructive pulmonary disease: A nationwide, population-based study. World J Gastroenterol 2019; 25(42): 6354-6364
- URL: https://www.wjgnet.com/1007-9327/full/v25/i42/6354.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i42.6354